Brief: Mersana Therapeutics Inc - Expect Capital Resources Will Support Current Operating Plan Commitments Into 2026

Mersana Therapeutics

05/01/2024 13:55

Jan 5 (Reuters) - Mersana Therapeutics Inc  MRSN.O :
    * EXPECT CAPITAL RESOURCES WILL SUPPORT CURRENT OPERATING
PLAN
COMMITMENTS INTO 2026
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF
SEPTEMBER
30, 2023 WERE $241.0 MILLION
    * PHASE 1 CLINICAL TRIAL OF XMT-2056, IMMUNOSYNTHEN HER2
ADC,
RESTARTING; PLAN TO ADVANCE DOSE ESCALATION IN 2024

Source text for Eikon:  ID:nGNX2W4ycp 
Further company coverage:  MRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))